Investor Relations

CELL THERAPIES.
INNOVATION. FUTURE.

SYNERGA.fund S.A. is a company listed on the NewConnect market operated by the Warsaw Stock Exchange.

Selected Financial Data and Forecasts

Financial results summary and forecast publication status.

Selected Financial Data (for Q1 2026)

Below is selected condensed financial data from the periodic report for Q1 2026 (data in PLN):

Financial Item 01.01.2026 - 31.03.2026
(Q1 2026)
01.01.2025 - 31.03.2025
(Q1 2025)
Net revenues from sales 0.00 PLN 0.00 PLN
Operating profit (loss) -23,608.02 PLN -18,438.70 PLN
Net profit (loss) -23,788.59 PLN -8,727.06 PLN
Balance Sheet (at end of period)
Total assets 20,474.96 PLN 2,337,638.94 PLN
Total equity -67,558.80 PLN 1,075,278.10 PLN
Total liabilities and provisions 88,033.76 PLN 1,262,360.84 PLN

Full Q1 2026 Report

Read the complete financial statements and management comments.

Download report (PDF)

Financial Forecasts

The company does not publish financial forecasts.

SYNERGA.fund Spółka Akcyjna

SYNERGA.fund S.A. is a company listed on the NewConnect market operated by the Warsaw Stock Exchange.

Ticker: SNG ISIN: PLMWTNS00010 NC Alert Financial services

Selected Financial Data and Forecasts

Financial results summary and forecast publication status.

Selected Financial Data (for Q1 2026)

Below is selected condensed financial data from the periodic report for Q1 2026 (data in PLN):

Financial Item 01.01.2026 - 31.03.2026
(Q1 2026)
01.01.2025 - 31.03.2025
(Q1 2025)
Net revenues from sales 0.00 PLN 0.00 PLN
Operating profit (loss) -23,608.02 PLN -18,438.70 PLN
Net profit (loss) -23,788.59 PLN -8,727.06 PLN
Balance Sheet (at end of period)
Total assets 20,474.96 PLN 2,337,638.94 PLN
Total equity -67,558.80 PLN 1,075,278.10 PLN
Total liabilities and provisions 88,033.76 PLN 1,262,360.84 PLN

Full Q1 2026 Report

Read the complete financial statements and management comments.

Download report (PDF)

Financial Forecasts

The company does not publish financial forecasts.